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In this study, three new hydrazide-based Schiff bases (1-3) have been synthesized via 
sonication  in good to excellent yield 73-90% and mainly characterized by UV-visible, 
IR, 1H-NMR and single crystal X-ray diffraction analysis. The crystal structure of 
compounds 1 and 2 is stabilized by N-H···O, C-H···O and C-H···N hydrogen bonds, as 
well as C-H···π contacts. In addition, weak π···π stacking interactions were observed in 
the structure of 2. A detailed analysis of the intermolecular interactions that stabilize the 
crystal packing has been performed by using Hirshfeld surface analysis and energy 
framework calculations were carried out to analyze and visualize the topology of the 
supramolecular assembly, indicating that the dispersion energy is dominant over 
electrostatic one in the most energetic dimers of both compounds. The interaction 
energies associated with the noncovalent interactions observed in the crystal structures 
and the interplay between them have been calculated using DFT calculations. Moreover, 
these intermolecular interactions were also characterized by using both Bader’s quantum 
theory of atoms in molecules (QTAIM) and NCI plots. The synthesized 
alkoxybenzylidene analogs of benzohydrazide and acetohydrazide were screened in vitro 
against soybean lipoxygenase and were found to show better activity than the standard 
indomethacin. Putative binding modes and comparison of binding interactions in the 
protein-ligand complex were analyzed by molecular docking studies. 
 
Keywords: Azomethine derivatives; noncovalent interactions; Hirshfeld surfaces; DFT 
calculations; Energy frameworks; LOX. 
 
1. Introduction 
Schiff bases are usually synthesized from the condensation reaction of carbonyl 
compounds with amine derivatives. The chemical and biological significance of Schiff 
bases can be attributed to the presence of lone pair electrons in the sp2 hybridized orbital 
of the nitrogen atom from the azomethine or imine group (-HC=N-). In addition, the metal 
complexes of these compounds show diverse pharmacological and biological activities 
including antibacterial [1], antifungal [2] and anticancer activity [3]. 
The chemistry of carbon-nitrogen double bond of hydrazone derivatives is fastly 
becoming the backbone of condensation reaction in benzo-fused N-heterocycles day by 
day [4]. Hydrazones constitute an important class of compounds for new drug 
development [5] and their chemical versatility is mainly attributed to the functional 





































































diversity of the azomethine –NHN=CH functional group which has nitrogen atoms with 
nucleophilic character, an imine carbon atom with both electrophilic and nucleophilic 
character and configurationally isomerism around the C=N bond. Many researchers have 
been synthesized these compounds as target structures and evaluated their various 
biological activities as well as structural properties. Hydrazides/hydrazones act as anti-
micobacterial [6], anti-viral, analgesic and anti-inflammatory agents [7], anti-platelet, 
vasodilator, anti-convulsant, anti-oxidant, diuretic and anti-malarial agents. Furthermore, 
these compounds show anti-trypanosomal, hormone antagonist, anti-arthritis [8] and 
acetylcholinesterase inhibitor activity [8, 9]. In addition, many investigations have 
reported that Schiff bases and hydrazones show a wide range of activities including anti-
inflammatory potentials [10].  
Noncovalent interactions have become attractive for structural chemists due to their 
crucial role in supramolecular chemistry, molecular recognition and materials chemistry 
[11]. The hydrogen bonding (HB) interactions are extremely important in biological 
systems as can be shown in nucleic acids where the assembly is controlled by a 
combination of H-bonds and π···π stacking interactions [12]. Actually, it is well-known 
that relatively weak intermolecular interactions such as C-H···X(X= halogens, O, S, N) 
hydrogen bonds play a crucial role in the crystal packing of different kinds of molecules 
[13-17]. 
In light of this background, we have reported herein the synthesis and characterization of 
three new hydrazide based Schiff bases derivatives 1-3 (scheme 1). The crystal structures 
of compounds 1 and 2 were solved by single crystal X-ray diffractions and the computed 
molecular structure has been investigated by DFT calculations at B3LYP/6-311G(d,p) 
level of theory. We have performed a complete analysis of the intermolecular interactions 
which are responsible of the crystal packing by using Hirshfeld surface analysis, energy 
frameworks and DFT calculations. In addition, the synthesized compounds were screened 
in vitro against soybean lipoxygenase and putative binding modes and comparison of 




2.1. Instrumentation.  Melting points were determined on a Yanaco melting point 
apparatus and are reported as uncorrected. FT-IR spectra were recorded on SHIMADZU 
FTIR-8400S spectrophotometer using KBr disc method. Similarly, UV spectra were 





































































recorded on SHIMADZU UV-1601 UV-visible spectrophotometer. 1H-NMR (300 MHz) 
spectra were measured on Bruker Avance instrument in d6-DMSO and TMS as internal 
standard. Reaction progress was monitored by thin layer chromatography (TLC). 2-
Hydroxybenzaldehye, 4-hydroxybenzaldehy, 1-bromopropane, 1-bromobutane and 1-
bromononane were supplied by Sigma-Aldrich, whereas different carboxylic acid 
hydrazides were prepared according to the literature methods [18, 19].  
 
2.2. General procedure for the synthesis of 1-3. An Erlenmeyer flask was charged with 
1 mmol of respective hydrazide, 1 mmol of alkoxy benzaldehyde and absolute ethanol 
(15 mL). 5-10 Drops of glacial acetic acid were added to catalyze the reaction. The 
reaction mixture was sonicated [20] for 2 hours at 55 ºC and progress of reaction was 
monitored through TLC. On completion, the reaction mixture was diluted with water and 
the precipitates formed were collected through filtration. The final products were  purified 
















1): R = 4-MeOPh, R' = 2-Propxy
2): R = Benzyl, R' = 4-Nonoxy
3): R = 4-NO2Ph, R' = 4-Butoxy
°
 
Scheme 1: Ultrasound assisted synthesis of compounds 1-3. 
 
Good quality single crystals of compounds 1-2 suitable for XRD analysis were grown 
from a mixture of EtOH and EtOAc (dissolving 150 mg of each compound in 5-10 mL 
of solvent) by slow evaporation over a period of 48 hours at ambient temperature. 
 
(E)-N'-(2-Propoxybenzylidene)-4-methoxybenzohydrazide (1) 
Light brown crystals (81%); Molecular formula: C18H20N2O3; Molecular weight = 312.14 
g/mol;  m.p. = 178-180 ºC; RF  = 0.42 (n-Hexane: EtOAc 7:3); Solubility: CHCl3/DMSO; 
λmax = 328.14 nm; FTIR (KBrcm-1): 3242 (N-H str.), 3037 (sp2 C-H str.), 2962 and 2864 
(sp3 C-H str.), 1658 (C=O str.), 1600-1461 (C=C aromatic str.), 1508(C=N str.), 1249 and 
1108 (C-O str.), 1172 (C-N str.), 1H-NMR (300 MHz, DMSO-d6):  δ 8.2(s, CH), 8.1( s, 
NH), 7.86-6.80 ( m, ArH), 3.94 ( t, 2H), 3.70 ( s, OCH3), 1.73 (sext, 2H), 0.94 (t, 3H). 






































































Off white crystals (90%); Molecular formula: C24H32N2O2; Molecular weight = 380.24 
g/mol; m.p. = 106-108 ºC, RF = 0.5 (n-Hexane: EtOAc 7:3); Solubility:CHCl3/DMSO; 
λmax = 306.49 nm; FTIR (KBr cm-1):3164 (N-H str.), 3066 (sp2 C-H str.), 2958 and 2920 
(sp3 C-H str.), 1666 (C=O str.), 1452-1593 (C=C aromatic str.), 1544 (C=N str.), 1247 
and 1014 (C-O str.), 1170 (C-N str.); 1H-NMR (300 MHz, DMSO-d6):  δ 8.2 (s, 1CH), 
8.0 (s, NH), 7.6-6.8 (m, 9ArH), 3.92 (t, 2H), 3.40( s, 2H), 1.70 (quin, 2H), 1.28 (m,10H), 
1.30 (quin, 2H), 0.96 ( t, 3H). 
 
(E)-N'-(4-Butoxybenzylidene)-4-nitrobenzohydrazide (3) 
Yellow crystals (73%); Molecular formula: C18H21N3O4;  Molecular weight = 343.15 
g/mol;  m.p. = 180-182 ºC,  RF = 0.43 (n-Hexane: EtOAc 7:3); Solubility:CHCl3/DMSO; 
λmax = 330 nm FTIR (KBr cm-1): 3253 (N-H str.), 3185 (sp2 C-H str.), 2962 and 2925 (sp3 
C-H str.), 1658 (C=O str.), 1467-1600 (C=C aromatic str.), 1521 (C=N str.), 1259 and 
1064 (C-O str.), 1164 (C-N str.), 1H-NMR (300 MHz, DMSO-d6):  δ 8.38-6.8 (m, 8ArH), 
8.2 (s, 1CH), 8.0 (s, 1NH), 3.92 (t, 2H), 1.70 (quin,  2H), 1.30 (sext, 2H), 0.92 (t, 3H). 
 
2.3. X-ray data collection and structure refinement. Suitable single crystals of 
compounds 1-2 were selected for X-ray analyses and diffraction data were collected on a 
Bruker Kappa APEX-II CCD detector with MoKα radiation at 100 K. Using the SADABS 
program semi emperical correction was applied [21]. SHELX program was also used to 
solve all structures by direct method [22]. Positions and anisotropic parameters of all non-
H atoms were refined on F2 using the full matrix least-squares technique. The H-atoms 
were added at geometrically calculated positions and refined using the riding model [23].  
For compound 2, the terminal six C-atoms of nonyl group (C16-C24) are disordered over 
three set of sites with occupancy ratio 0.46(2): 0.376(17): 0.17(2). All the disordered 
atoms are refined anisotropically with bond distance and bond angles are restrained. The 
atoms in each part are refined to have similar thermal parameters. Anisotropic 
displacement parameters of each part of individual atom are made equal to each other. 
The details of crystallographic data  and crystal refinement parameters for the compounds 
1-2 are given in Table 1. 
 
2.4. Hirshfeld surface calculations. Hirshfeld surfaces and their associated two-
dimensional fingerprint plots [24-27] were calculated by using the CrystalExplorer17.5 





































































program [28]. The normalized contact distance (dnorm) surface and the breakdown of two 
dimensional fingerprint plots were used for identification and quantifying intermolecular 
interactions that are relevant in the crystal lattice. The dnorm function is based on both de 
(the distance from the point to the nearest nucleus external to the surface) and di (the 
distance to the nearest nucleus internal to the surface) and the van der Waals (vdW) radii 
of the atoms. Graphical plots of the molecular Hirshfeld surfaces mapped over dnorm 
function show a red-white-blue color scheme, where red highlights shorter contacts, white 
is used for contacts around the vdW separation, and blue is for longer contacts. 3D dnorm 
surfaces were mapped over a fixed color scale of -0.075 au (red)-0.75 au (blue). The shape 
index were mapped in the color range -1.00 au (concave) to 1.00 (convex), and curvedness 
in the range of -4.00 au (flat)-0.01 au (singular). The 2D fingerprint plots were generated 
by using the translated 0.6-2.6 Å range, and including reciprocal contacts.  
 
Table 1: Crystallographic data and details of refinements for compounds (1-2). 
           1            2 
CCDC 1963584 1963585 
Chemical formula C18H20N2O3 C24H32N2O2 
Mr 312.36 380.51 
Crystal system, space group Monoclinic, P21/c Orthorhombic, Pca21 
Temperature (K) 296 296 
a, b, c (Å) 23.896 (8), 4.9911 (17), 13.723 
(4) 
9.695 (13), 24.70 (3), 9.476 (10) 
β (°) 102.782 (12)   ----- 
V (Å3) 1596.1 (9) 2269 (5) 
Z 4 4 
Radiation type Mo Kα Mo Kα 
µ (mm-1) 0.09 0.07 
Crystal size (mm) 0.38 × 0.26 × 0.16 0.38 × 0.24 × 0.20 
Diffractometer Bruker Kappa APEXII CCD Bruker Kappa APEXII CCD 
Absorption correction Multi-scan  
(SADABS; Bruker, 2005) 
Multi-scan  
(SADABS; Bruker, 2005) 
 Tmin, Tmax 0.895, 0.955 0.885, 0.965 
No. of measured, independent 
and 
 observed [I > 2σ(I)] reflections 
18062, 3836, 2243   10378, 2195, 1090   
Rint 0.069 0.084 
(sin θ/λ)max (Å-1) 0.661 0.600 
R[F2 > 2σ(F2)], wR(F2), S 0.058,  0.138,  1.01 0.055,  0.130,  1.01 
No. of reflections 3836 2195 





































































No. of parameters 210 291 
No. of restraints 121 130 
H-atom treatment H-atom parameters constrained H-atom parameters constrained 
∆〉max, ∆〉min (e Å-3) 0.18, -0.20 0.13, -0.14 
 
2.5. Interaction energies and energy framework analysis. To calculate, visualize and 
analyse the 3D energy frameworks along with the intermolecular interaction energies we 
have used the CrystalExplorer17.5 software. The single point molecular wavefunction at 
B3LYP/6-31G(d,p)  level of theory  is used to calculate the energy by generating a cluster 
of radius 3.8 Å around the molecule. The neighbouring molecules in the shell around the 
central molecule are generated by applying crystallographic symmetry operations [29, 
30]. 
 
2.6. Computational details. The overall quantum chemical calculations for compounds 
1-2 were performed by using the Gaussian09 software [31]. The molecular structure of 
the compounds were optimized using single crystal XRD geometries at B3LYP/6-
311G(d,p) level of theory [32, 33]. The frequency analysis was also carried out with the 
same level of theory for verification of stability related with optimized geometries. 
Electronic transitions were computed within the Time-Dependent Density Functional 
Theory (TD-DFT) [34] taking into account implicitly the solvent effect (ethanol).  
To compute the interaction energies in the solid state we have used the crystallographic 
coordinates at the B3LYP-D3/def2-TZVP level of theory. The D3 Grimme’s dispersion 
correction was used for an adequate evaluation of non-covalent interactions where 
dispersion effects are relevant [35]. The quantum theory of atoms in molecules (QTAIM) 
analysis [36] has been carried out at the same level of theory and using the AIM2000 
program [37]. The NCI plot isosurfaces were also used to characterize the non-covalent 
interactions [38]. These surfaces indicate favorable and unfavorable interactions, as 
differentiated by the sign of the second density Hessian eigenvalue and defined by the 
isosurface color. The color scheme is red-yellow-green-blue with red for repulsive and 
blue for attractive.  
 
2.7. In vitro Lipoxygnase inhibition studies (1-3). Soybean lipoxygenase enzyme has 
been used as an in-vitro biochemical model for the determination of anti-inflammatory 
potentials [39]. Similarly, indomethacin was used as reference drug. The lipoxygenase 





































































activity of synthesized compounds (1-3) was determined by spectrophotometric method 
with slight modification [40]. Inhibition was determined by measuring the loss of soybean 
15-LOX activity (5 μg) with 0.2 μM linoleic acid as the substrate prepared in borate buffer 
(0.2 M, pH 9.0). The inhibition in triplicate at various concentrations of synthetic 
compounds were recorded at 234 nm using UV-Vis spectrophotometer. Indomethacin 
was used as positive control, while methanol was used as negative control [41]. 
IC50 indicating the concentration of 50% inhibition was calculated. Soybean lipoxygenase 
inhibition data is reported in IC50 values. 
 
2.8. Molecular modeling study. All docking studies were performed using Autodock 
Vina (ver. 1.5.6) [42]. For this purpose, the crystal structure of soybean lipoxygenase 
complexed with 13-(S)-hydroproxy-9(Z)-2,11(E)-octadecadienoic acid (code ID: 1IK3) 
were retrieved from protein data bank. The co-crystallized ligand and water molecules 
were removed, and the protein was converted to pdbqt format using Autodock Tools [43]. 
The 2D structures of ligands were sketched using Chemdraw 12.0. the 2D structures were 
converted to 3D format by Openbabel (ver. 2.3.1) [44]. PDBQT files were prepared in 
MGL Tools [43]. The docking parameters were set as follows: size_x =  40;  size_y = 40; 
size_z = 40; center_x = 27.458; center_y = 4.218; center_z = 15.623. The other 
parameters were left as default. Finally, the conformations with the most favorable free 
energy of binding were selected for analyzing the interactions between the target enzyme 
and inhibitors. PyMOL version 1.8.8.2 [45] and Chimera 1.6 software [46] was used for 
3D molecular graphics, structural alignments and visualizations. Physicochemical 
properties were calculated using SwissADME [47]. 
 
3. Results and discussion 
3.1. Synthesis and characterization 
The compounds under study were synthesized by a procedure simple and faster. 
Equimolar quantities of the respective hydrazine and alkoxy benzaldehyde in ethanol as 
solvent in the presence of acetic acid, react by sonication during 2 hours at 55 ºC leading 
the corresponding hydrazone derivatives (1-3). Re-crystallization from ethanol affords 
the products 1 and 2 as crystalline solids in good yields. For 3, only very small and 
twinned crystals with low X-ray scattering ability were obtained. 
The IR spectra of compounds 1-3 are shown in Figure S1, ESI. The main features 
associated with the hydrazone moiety, -C(O)-NH-N=C- will be discussed. The medium 





































































intensity band at 3233, 3235 and 3233 cm-1 for 1, 2 and 3, respectively are assigned to 
ν(N-H) stretching mode. The ν(C=O) stretching mode is observed at 1656 cm-1 in the IR 
spectrum of 1 (calculated 1710 cm-1) and as a strong infrared absorption at 1666 cm-1 for 
compound 2 (calculated 1730 cm-1). The ν(C=O) stretching vibration is located at 1658 
cm-1 in the IR spectra of 3. The δ(N-H) bending mode of the amide group, in general 
appears as a very intense absorption in the 1600-1500 cm-1. The IR spectra show medium 
intensity absorptions at around 1535, 1559 and 1561 cm-1 for 1, 2 and 3, respectively, in 
agreement with related compounds [48]. The weak bands located at 1124 for 1, 1147 cm-
1 for 2 and 1139 cm-1 for 3 are assigned to the ν(N-N) stretching mode. Finally, the band 
corresponding to the ν(C=N) stretching mode in Schiff bases is generally observed in the 
range 1650-1600 cm-1 [3, 17]. For the studied compounds, we have assigned this mode 
to the absorptions observed at 1648, 1643 and 1651 cm-1 for 1, 2 and 3, respectively. 
The electronic spectra of compounds 1-3 are shown in Figure S2, ESI. The absorption 
bands at 327 and 307 and 332 nm for 1, 2 and 3, respectively are assigned to HOMO-
LUMO electronic transitions with π → π* nature. 
The 1H NMR (300 MHz, d6-DMSO) data for compounds 1-3 show singlet signals in the 
δ = 8.0-8.1 ppm range, corresponding to the N-H protons of the amide group. The singlet 
at δ = 8.2 ppm observed in the spectra of all compounds is assigned to the proton of the 
azomethine moiety. The protons of the aromatic rings are observed in the region δ = 8.38-
6.80 ppm.  
 
3.2. Description of crystal structures of compounds 1-2. 
Although the main difference between the compounds are simply the substituents and 
their substitution positions, the resulting conformations, crystal systems and space groups 
of both compounds are different. The crystallographic study showed that compound 1 
crystallizes in the monoclinic form with P21/c space group, whereas 2 exists in the 
orthorhombic crystal system, space group Pca21. Both compounds accommodate four 
molecules per unit cell.  
Figure 1a and 2a show a view of the molecular structure of compounds 1 and 2, 
respectively. Selected X-ray bond lengths and angles, together with the computed values 
at B3LYP/6-311G(d,p) approximation are shown in Table 2. The optimized molecular 
structure of both compounds are shown in Figures S3-S4, ESI. In the crystal structure of 
1, the 4-methoxybenzene moiety A (C1-C7/O1), the linker moiety 1-methyl-2-
methylenehydrazine B (C8/N1/N2/C9), phenyl ring C (C10-C15) and propanoxy group 





































































D (O3/C16-C18) are planar with r. m. s. deviation of  0.0103, 0.0063, 0.0101 and 0.0788 
Å, respectively. The carbonyl O-atom is at a distance of 1.525(6) Å and -1.035 (5) Å from 
the mean planes A and B, respectively. The dihedral angles between A/B, B/C and C/D 
are 30.99(18)°, 29.41(18)° and 12.74(14)°, respectively. The moiety A and C are twisted 
at 14.32(12)°, associated with different packing interactions. In 2 (Figure 2a), the terminal 
C-atoms of the nonoxy group are disordered. The disorder is resolved for last four C-
atoms with occupancy ratio of  0.54(2): 0.46(2). The benzyl group A (C1-C7), the linker 
moiety B (C8/N1/N2/O1) and the part of 4-methyl phenol part C (C9-C15/O2) are planar 
with r.m.s. deviation of 0.0165, 0.0022 and 0.0105 Å, respectively. The dihedral angle 
between A/B, A/C and B/C is 69.72(18)°, 86.93(13)° and 28.92(27)°, respectively. 
As shown in Table 2, the imine N2-C9 bond lengths are 1.272(3) and 1.271(6) Å for 1 
and 2, respectively. These bond lengths are significantly shorter than N1-N2 and N1-C8 
bond lengths in agreement with the typical N2=C9 double bond character. The C9-C10 
bond lengths are 1.470(3) Å for 1 and 1.452(7) Å for 2, which are indicative of the single 
bond character of this bond. The bond angle N1-N2-C9 are 115.2(2)º for 1 and 114.9(4)º 
for 2, which are significantly smaller than the ideal value of 120º expected for N-atoms 
sp2-hybridized. This is probably a consequence of repulsion between the nitrogen lone 
pairs and the adjacent N-N bond. The C=O bond lengths are similar for both compounds, 
with values of 1.223(3) and 1.220(6) Å for 1 and 2, respectively. These results indicate 
that the C=O bond length is not influenced with the substituents. The C-O bond length 
corresponding to 2-propoxy in 1 is slightly longer (1.368 Å) in comparison with the C-O 
distance in the 4-nonoxy substituent in 2 (1.362 Å), demonstrating a smaller π-donating 
effect of the alkoxy O-atom against the aromatic ring. 
In accordance with Table 2, a good agreement between experimental and computed 
geometrical parameters has been observed. It is important to mention that the calculations 
were carried out in gas phase where the crystal packing effects are completely ignored. 
Notably, the larger discrepancies are observed for the C8-N1 and N1-N2 bonds, which 
errors are about 0.03 and 0.023 Å, respectively. Calculated and experimental angles and 
dihedral angles are in very good agreement indicating that both molecules undergo small 
changes due to intermolecular interactions, as shown in the calculated and experimental 
molecular structures.  
 






































































Figure 1. a) ORTEP diagram of 1 at 30 % probability level along with the numbering 
scheme; b) dimer of 1 (Motif 1, M1) showing the formation of N-H···O, C-H···O 
hydrogen bonds and C-H···π interactions; c) formation of intermolecular C-H···π 
interactions (M2), d) dimer of 1 stacked through C-H···O hydrogen bonds (M3). 
 
Figure 2. a) ORTEP diagram of 2 with ellipsoids at 30% probability level with non H-
atoms numbering scheme. The molecular structure reveals disorder in the alkyl chain; b) 
Structural motif showing a combination of C-H···O and C-H···N hydrogen bonds (green 
dashed lines) and C-H···π (blue dashed lines) interactions; c) Formation of N-H···O 
hydrogen bonds and C-H···π interactions. In Fig. 2b and 2c, only the major occupancy 
disordered atoms are shown (see text). 





































































Table 2. Selected experimental and computed geometrical parameters (Å, º) for 
compounds 1-2. 
 
Parameters Compound 1 Compound 2 
 Exp. Calcd.a Exp. Calcd. 
C1-C8 1.486(3) 1.498 - - 
C7-C8 - - 1.501(7) 1.531 
C8-O3 1.223(3) 1.212 - - 
C8-O1 - - 1.220(6) 1.209 
C8-N1 1.358(3) 1.390 1.356(6) 1.383 
N1-N2 1.378(3) 1.355 1.381(6) 1.358 
C9-N2 1.272(3) 1.281 1.271(6) 1.279 
C9-C10 1.470(3) 1.463 1.452(7) 1.460 
C4-O1 1.368(3) 1.359 - - 
C15-O2 1.368(3) 1.365 - - 
C13-O2 - - 1.362(7) 1.359 
C1-C8-N1 115.2(2) 114.3 - - 
C7-C8-N1 - - 112.6(4) 113.1 
C8-N1-N2 119.9(2) 121.0 121.5(4) 121.5 
N1-N2-C9 115.2(2) 117.2 114.9(4) 117.4 
N2-C9-C10 120.2(2) 121.1 121.4(4) 122.2 
C1-C8-N1-N2 -178.5(2) 177.7 - - 
C7-C8-N1-N2 - - 179.8(4) 177.1 
C8-N1-N2-C9 178.8(2) 173.7 -170.5(4) -176.8 
N1-N2-C9-C10 -173.9(2) 179.6 179.6(4) 179.6 
             a Calculated at B3LYP/6-311G(d,p) level of theory. 
 
The geometrical parameters of the hydrogen bonding interactions for compounds 1 and 2 
are displayed in Table 3. The molecule of 1 has a methoxy substituent on the arene ring 
(C1-C6) in the para-position (see Fig. 1a). In the crystal packing of 1, the molecules are 
connected with each other in the form of dimers through N1-H1···O3 and C9-H9···O3 
interactions, where O3 atom from the carbonyl group acts as acceptor (Figure 1b). The 
former is the strongest interaction as reflected by the geometrical parameters reported in 
Table 3. The stabilization of the crystal structure is also supported by the presence of 
weak C-H···O interactions involving the O3 from the carbonyl as acceptor and the H7A 
of the methoxy group located in the para-position in the benzohydrazide moiety (Figure 
1c). In addition, the molecule of 2 has a propoxy group located at the orto position of the 
phenyl ring (C10-C15). This propoxy group is involved in C-H···π interactions of the 
type C16-H16A···Cg2 [d(H16···Cg2) = 2.63 Å, <(C16-H16A···Cg2) = 151º] (Figure 1a). 
The structure is also stabilized by C2-H2···Cg2 [d(H2···Cg2) = 3.22 Å, <(C2-H2···Cg2) 





































































= 156º] (Figure 1b) involving the phenyl ring Cg2 (C10-C15). The phenyl rings are not 
involved in π···π stacking interactions, as compared with the packing of 2 (see below). 
 
Table 3. Geometrical parameters (Å, º) of hydrogen bonds in compounds 1 and 2. 
 
D-H···A D-H H···A D···A <(D-H···A) 
Compound 1     
N1-H1···O3i 0.86 2.16 2.916(2) 146.1 
C9-H9···O3i 0.93 2.67 3.349(2) 130.6 
C7-H7A···O3ii 0.96 2.64 3.530(2) 153.8 
Compound 2     
N1-H1···O1iii 0.86 2.17 2.918(3) 145.9 
C7-H7A···O1iv 0.97 2.58 3.521(3) 162.9 
C6-H6···N1iv 0.93 2.72 3.546(3) 147.8 
Symmetry codes: (i) x, y+1, z; (ii) x, -y-1/2, +z-1/2; (iii) x+1/2, 
-y, z; (iv) –x+1/2+1, y, +z-1/2. 
 
The crystal packing of 2 exhibits an interesting structural pattern characterized by 
different structural motifs. The amide O1 and N1 atoms act as acceptors forming C7-
H7A···O1 [d(H7···O1) = 2.583(3) Å] and C6-H6···N1 [d(H6···N1) = 2.724(2) Å] 
hydrogen bonds (Figure 2b).  The C-H···N hydrogen bonds are absent in the crystal 
packing of 1 because the orientation of the benzyl moiety favors this interaction. In 
addition, this structural motif is also stabilized by C-H···π interactions (C14-H14···Cg2) 
with inter-centroid H14···Cg2 distance of 3.415 Å (Figure 2b). As shown in Figure 2c, 
the supramolecular assembly of 2 is governed by N1-H1···O1 hydrogen bonds 
[d(H1···O1) = 2.165(2) Å] and C-H···π interactions involving the H9 atom of the 
azomethine group and the Cg1 (C1-C6) centroid. The crystal packing of 2 shows weak 
π···π stacking interactions between the Cg1 (C1-C6) and Cg2 (C10-C16) centroids, with 
Cg1···Cg2 inter-centroid distance of 4.817(6) Å (symmetry code: 1-x,-y, -1/2+z). 
 
3.3. Hirshfeld surface analysis 
Hirshfeld surface analyses have been carried out in order to get further insights into the 
packing motifs and the contributions of the main intermolecular interactions that are 
responsible for the crystal stabilization of compound 1. We have not performed Hirshfeld 
surface analysis of compound 2 due to the molecular disorder observed. Recently, 
Hirshfeld surface analysis for different hydrazide Schiff bases were evaluated for a better 
comprehension of their crystal packing [49]. Figure 3a shows Hirshfeld surfaces mapped 
over dnorm function in two orientations. The corresponding full two-dimensional 





































































fingerprint plots and resolved to show H···C/C···H and H···O/O···H contacts are 





Figure 3. (a) Hirshfeld surfaces of 1 mapped over dnorm property in two orientations: The 
second molecule rotated 180º around the vertical axis of the plot. The labels are discussed 
in the main text. (b) Full and decomposed two dimensional fingerprint plots for 
compound 1 showing percentage contributions to the total Hirshfeld surface area of the 
molecules. 
 
H···H contacts represent the largest contribution (48.6 %) to the Hirshfeld surface area, 
and they are highlighted in the middle of scattered points in the fingerprint plots at (de + 
di) ≈ 2.4 Å, which is the sum of the vdW radii.  
The two larger red spots labeled 1 in the dnorm surfaces of 1 are attributed to N-H···O 
hydrogen bonds, involving the O3 atom as acceptor. Another red areas labeled 2 in the 
surfaces are due to the formation of C-H···O hydrogen bonds between the H7A of the 
methoxy substituent and the O-atom from the carbonyl group.  These type of interactions 
have been evaluated extensively in dihydropyrimidine-2(1H)-thione derivatives and in 1-





































































(adamantine-1-carbonyl)-3-substituted thioureas [50]. The H···O/O···H contacts are also 
visible in the fingerprint plots (Figure 3b) as a pair of symmetrical sharp spikes at (de + 
di) ≈ 2.1 Å and contribute 15.7% to the total Hirshfeld surface area.  
The presence of H···C/C···H contacts are easily visible in the dnorm maps as red regions 
labeled 3 for compound 1. The spot labeled 3 is attributed to C-H···π interactions 
involving the centroid Cg2 (C10-C15) and the H2 atom from a neighboring molecule 
(H2···Cg2 distance of 3.22 Å). These features support the importance of the C-H···π 
interactions in the supramolecular assembly of compound 1. These interactions are also 
visible as a pair of wings in the top left and bottom right region of the 2D fingerprint plots 
(indicated by red encircles in Figure 3b), with the shortest (de + di) ≈ 3.0 Å. Furthermore, 
the shape of the wings and the sum of de and di are indicative of the relevance of the C-
H···π interaction.  
 
3.4. Interactions energies and energy frameworks 
In order to describe the intermolecular interactions in a whole-of-molecule approach, we 
have analyzed the separate electrostatic and dispersion contributions to the total 
interaction energy. The interactions were calculated using the B3LYP/6-31G(d,p) energy 
model implemented in CrystalExplorer17.5 program. In the calculation, the total energy 
is modelled as the sum of the electrostatic (Eele), polarization (Epol), dispersion (Edis) and 
exchange-repulsion (Erep) terms [30, 51]. The main intermolecular interactions observed 
in the crystal structure of compound 1 are listed in Table 4 along with the respective 
interaction energies.  
The highest total energy of -71.6 kJ/mol corresponds to a molecular pair (Motif 1, Figure 
1b) formed by the bifurcated N1-H1···O3 and C9-H9···O3 hydrogen bonds, being the 
N1-H1···O3 the strongest interaction, in accordance with the geometrical parameters 
reported in Table 3 and 4. This motif is further supported by presence of C-H···π 
interactions involving the H16A of the methylene group and the Cg2 centroid. The 
dispersion (58.96%) and electrostatic (41.08%) energies contribute towards the 
stabilization of this molecular pair. Motif 2 is established through an intermolecular C2-
H2···Cg2 interaction resulting in the overall stabilization energy of -41.4 kJ/mol, with 
72.13% contribution from dispersion component towards stabilization. Motif 3 is 
stabilized by the presence of weak intermolecular C-H···O interactions involving the 
H7A of the methoxy group and the O3 atom (Figure 1d), [Etot = -28.4 kJ/mol with 
contributions of 64.5% dispersion energy and 35.49% electrostatic energy]. 






































































Table 4. Intermolecular interactions along with the geometrical parameters (Å, º) and 
respective interaction energies (Etot) partitioned into electrostatic (Eele), polarization 
(Epol), dispersion (Edis) and exchange-repulsion (Erep) energy components. The energy 
values are expressed in kJ/mol. 
Motif Symmetry Interactions d(H···A/Cg), 
<(D-H···A)a 
Eele Epol Edis Erep Etot 
Compound 1         
M1 x, y, x N1-H1···O3 2.643, 154 -38.2 -13.1 -73.7 68.9 -71.6 
  C9-H9···O3 2.668, 131      
  C16-H16A···Cg2 2.630, 151      
M2 x, -y+1/2, z+1/2 C2-H2···Cg2 3.220, 156 -15.5 -3.20 -48.4 31.8 -41.4 
M3 x, -y+1/2, z+1/2 C7-H7···O3 2.643, 154 -9.20 -6.10 -27.8 16.3 -28.4 
 
a Geometrical parameters of hydrogen bonds (Å, º) and H···Cg distance (Å), Cg1 and 
Cg2 are the centroids of the C1-C6 and C10-C16 rings, respectively. 
 
Figure 4 shows graphically the 3D topology of interactions energies in the form of energy 
frameworks, which provide a view of supramolecular assembly of crystals through 
cylinders joining centroids of molecular pairs by using red, green and blue color codes 
for the components electrostatic, dispersion and total energy, respectively. The radius of 
the cylinders is proportional to the magnitude of the interaction energies.  
For compound 1, the partial sum of dispersion energies (-149.9 kJ/mol) is greater than 
that electrostatic ones (-62.9 kJ/mol), which evidences a clear dominance of dispersion 
energy over the electrostatic component. This observation is in agreement with the higher 
diameter of the cylindrical tubes for dispersion interaction in comparison to that of the 




Figure 4. Energy frameworks along a-axis for compound 1, showing the electrostatic 
(left, red), dispersion (middle, green) and total interaction energy (right, blue). The energy 
scale factor of 90 kJ/mol was used with a cut-off value of 5 kJ/mol. 





































































3.5. Theoretical study 
The theoretical study performed in this work is mainly focused to the analysis of hydrogen 
bonds and C-H···π interactions observed in the crystal structure of compounds 1 and 2. 
These interactions were studied by using NCI plots and QTAIM analysis. These 
interactions play a crucial role in the biological properties observed for these compounds 
which were correlated with docking studies (see below). 
The molecular electrostatic potential (MEP) surfaces of 1 and 2 are shown in Figure 5. 
In both compounds, the most negative region is located at the O-atom from the carbonyl 
group, with MEP values of -194 and -189 kJ/mol for 1 and 2, respectively. The most 
positive values are observed at the H-atoms from the amide group. Therefore, the 





Figure 5. MEP surfaces of compounds 1 (a) and 2 (b) plotted onto the 0.001 a.u. 
isosurface. The values at the selected points on the surface are given in kJ/mol. 
 





































































Interestingly, the MEP values are also negative over the aromatic rings in both 
compounds, thus both π-systems could interact with positive regions such as aliphatic and 
aromatic H-atoms to form C-H···π interactions.  
We have selected the hydrogen bonding network shown in Figures 1 and 2 to analyze the 
energetic features in both compounds. For simplicity, in the first theoretical model used 
for the analysis (Fig. 6a), we have replaced the 4-methoxyphenyl ring by a methyl group 
(red arrow) and we have reduced by one the number of methylene groups in the propoxy 
moiety of 1. It shows a moderately strong dimerization energy (ΔE1 = -64.2 kJ/mol) due 
to the formation of N-H···O and C-H···O hydrogen bonds. Interestingly, this motif is also 
stabilized by C-H···π interactions. In the second model of 1 (Fig. 6b), we have replaced 
the 2-propoxyphenyl ring by a methyl group. In this dimer, the dimerization energy is 
reduced to ΔE2 = -26.2 kJ/mol due to the presence of C-H···O hydrogen bonds. 
For compound 2, the theoretical models used consist in the replacing of the -O-(CH2)8-
CH3 group by an H-atom, indicated by a red arrow in Figures 6c. In the first model of 2 
(Fig. 6c), a combination of C-H···O, C-H···N and C-H···π interactions are formed, with 
a dimerization energy of ΔE3 = -55.8 kJ/mol. The dimerization energy of the second 
model (Fig. 6d) is somewhat greater that of the first model due to the presence of a 
combination of a strong N-H···O hydrogen bonds with C-H···π interactions involving the 
H-atom of the azomethine group. These results are in agreement with the interaction 
energies obtained from the crystal structure (see Table 4) by using the 
CrystalExplorer17.5 program. 
 






































































Figure 6. (a, b) Dimers of models of compound 1 showing hydrogen bonds and C-H···π 
interactions, distances in Å. (c, d) Dimers of theoretical models of compound 2. 
 
In order to characterize the C-H···π and hydrogen bonding interactions, we have 
computed the NCI plots using the B3LYP-D3/def2-TZVP wavefunction. The NCI plot is 
an important tool to visualize the effectiveness of the non-covalent interactions. The color 
scheme is a red-yellow-green-blue scale with red (repulsive) and blue (attractive) regions. 
Yellow and green surfaces indicate weak repulsive and weak attractive interactions, 
respectively. Figure 7 shows a NCI plot for the first theoretical model of 1 showed in 
Fig. 6a. The presence of large green isosurface located between the methylene group and 
the phenyl ring confirms the existence of C-H···π interactions. The light blue isosurface 
located between the O-atom from the carbonyl group and the N-H moiety is an indicative 
of a strong hydrogen bond between both groups. To characterize these hydrogen bonding 
interactions, we have used the Bader’s quantum theory of atoms in molecules (QTAIM) 
[36]. The distribution of bond critical points (BCP) and bond paths of the N-H···O and 
C-H···O hydrogen bonds is highlighted in the right panel of Figure 7. In this 
representation we have observed the presence of two BCP (represented by red spheres) 
and bond paths connecting the O-atom from the carbonyl group with the H-atoms of the 
N-H and C-H moieties. The values of charge density and interaction energy are also 
indicated in Figure 7. These values are within the range 0.002-0.04 a.u. proposed by 
Koch and Popelier [52] for hydrogen bonding interactions. The charge density of BCP1 
(N-H···O H-bond) is the largest one indicating the stronger interaction compared with C-
H···O hydrogen bond (BCP2). The interaction energy of each hydrogen bonding contact 
can be estimated according to the approach proposed by Emamian and co-workers [53]. 





































































The energies are indicated in Figure 7, and they evidence that the contribution of N-H···O 
is -10.10 kJ/mol and that the C-H···O bonds involving the H-atom of the imine group is 




Figure 7. Left: NCI surface of a dimer of compound 1. The gradient cut-off is 0.35 a.u. 
and the color scale is -0.4 < ρ < +0.4 a.u. Right: QTAIM distribution of bond and ring 
critical points (red and yellow spheres, respectively) and bond paths calculated at B3LYP-
D3/def2-TZVP level of theory of the H-bonded fragment. 
 
The NCI plot index surfaces obtained for both theoretical dimers of compound 2 are 
shown in Figure 8. For the first dimer (Fig. 8a), the C-H···π interactions are characterized 
by green isosurfaces located between the π-cloud of the phenyl ring and the aromatic H-
atom of other molecule. In addition, the NCI plot also reveals the existence of C-H···O 
and C-H···N hydrogen bonds. Similar features were observed for the second dimer of 2 
(Fig. 8b), in which the C-H···π interaction is also confirmed by the green isosurface 
located between the H9 atom from the azomethine moiety and the phenyl ring. For the 
later dimer, the N-H···O hydrogen bond is characterized by small blue isosurfaces located 
between the O-atom and the amino groups. 
 






































































Figure 8. NCI plots of the two dimers of compound 2. The gradient cut-off is 0.35 a.u. 
and the color scale is -0.4 < ρ < +0.4 a.u. 
 
3.6. In vitro Lipoxygenase Inhibition Activity of Compounds 1-3. 
Lipoxygenases  (EC  1.13.11.12,  linoleate: oxygen,  oxidoreductases,  LOXs)  which  are  
widely  distributed  in  plants,  animals,  and  fungi,  are  a  huge  monomeric  protein  
family  with  non-heme,  non-sulphur,   iron   cofactor   containing   dioxygenases   that   
catalyze   the   oxidation   of   polyunsaturated fatty acids (PUFA) as substrate with at  
least one 1Z, 4Z-pentadiene moiety such as linoleic, linolenic and arachidonic acid to 
yield hydroperoxides [54]. 
Therapeutic efficacy of the synthesized compounds for the inflammation depends upon 
the inhibition of LOX.  The substituted alkoxybenzylidene benzohydrazides (1 and 3) and 
alkoxybenzylidene)-2-phenylacetohydrazide (2) were evaluated against soybean 
lipoxygenase enzyme using indomethacin as a standard drug (IC50 = 48.25±1.71 µM) 
(Table 5). Compound 3 bearing 4-nitro functionality displayed better activity in 
comparison to the standard indomethacin (IC50 = 45.31±2.11 µM) (Table 5) while 
compounds 1 and 2 showed less activity as compared to indomethacin. Structure activity 
relationship shows that the substituted alkoxybenzylidene benzohydrazides (1 and 3) 
were found to inhibit Lipoxygenase enzyme to a greater extent as compared to 
alkoxybenzylidene)-2-phenylacetohydrazide (2) which also depicts that activity is greater 
when both the aryl rings are conjugated to central hydrazine moiety (compounds 1 and 3) 
as compared with 2 when conjugation is discontinued in case of phenyl acetohydrazide.  
Putative binding modes and comparison of binding interactions can further be analyzed 
by molecular docking studies. 
 
 





































































Table 5. Inhibitory activity of the alkoxy aryl hydrazones (1-3) evaluated against 
soybean lipoxygenase enzyme. 























 Indomethacin 48.25±1.71 
 
3.7. Molecular docking Studies  
The N-aroylhydrazones (NAH) moiety has been known for their amide and imine 
functions, NAH compounds may exist as C=N double bond stereoisomers (E/Z) and as 
syn/antiperiplanar conformers/rotamers about the amide CO-NH bond. As is evident 
experimentally from their crystal structures that all the three compounds exist as E 
stereoisomers in their most stable antiperiplanar conformation. Therefore, the molecular 
docking studies in complex with lipoxygenase enzyme was carried out using 
antiperiplanar conformations of E isomers for binding studies. 
The difference between inhibitory activities of analogues studied in this work led us to 
make structural comparisons in terms of their intermolecular interactions that mediate 
protein-ligand binding, their relative location in active site, their size, shape, 
physicochemical properties, etc. In order to investigate the binding mode of the inhibitors 
and their interaction with amino acid residues of lipoxygenase (PDB ID: 1IK3), molecular 
docking study of synthesized compounds was performed. Docking study further assisted 
in the identification of the relative location of the co-crystallized inhibitors and reference 
molecule in the protein architecture of lipoxygenase. Indomethacin was used as the 
reference drug in biological screening; therefore, it was also docked with the enzyme to 
know its binding interaction. Results were analyzed and discussed below. 
 






































































Descriptors such as number of rotatable bonds, hydrogen bond donors, hydrogen bond 
acceptors, Lipinski’s acceptors, Lipinski’s donors, Lipinski’s violation, Lipinski’s 
druglikeness, logP, molecular weight and total polar surface area (TPSA) were computed 
to access the druglike properties of the synthesized compounds. In silico calculation 
results revealed that all the synthesized compounds fulfilled the Lipinski’s Ro5 [55] and 
Veber’s Ro3 [56] cut-off limits, which paved the way towards their capability of 
inhibiting the activities against lipoxygenase. 
The molecules to be considered as drug like must have molecular weight ≤ 500, log P 
(logarithm of the octanol/water partition coefficient ) ≤ 5, total polar surface area (TPSA) 
< 140 Å², number of hydrogen bond donors (HBD) ≤ 5 and hydrogen bond acceptor 
(HBA) ≤ 10, as per Lipinski’s Ro5 [55].  Veber et al offered further modifications in Ro5 
[56]. According to Veber, number of rotatable bonds (NOR) of a druglike molecule 
should be fewer or equal to 10 [55]. Molecules which violate more than one of these 
criteria may have problems with their bioavailability. Detailed results of druglikeness of 
the hydrazones under study are tabulated in Table 6.  It has been observed that all the 
compounds fulfill the criteria to be considered as drug-like molecules as shown in Table 
6. The Log P value of the compounds indicates good absorption of hydrazones (1-3). 
After analysis physicochemical properties, the compounds are subjected to docking 
analysis. 
Table 6. Drug-likeness descriptors of the compounds 1-3. 
Physicochemical Property 
descriptor Compound 1 Compound 2 Compound 3 Indomethacin 
Formula C18H20N2O3 C24H32N2O2 C18H19N3O4 C19H16ClNO4 
Molecular weight (g/mol) 312.36  380.52  341.36 357.79 
NoR 8 14 9 5 
HBA 4 3 5 4 
HBD 1 1 1 1 
Log P (o/w) 3.41              4.61                           3.06 2.76 
TPSA  59.92 Å²          50.69 Å²      96.51 Å² 68.53 Å² 
Abbreviations used: NoR= Number of rotatable bonds; HBA= Hydrogen bond acceptor; HBD = Hydrogen bond 









































































3.7.2. Lipoxygenase Structure 
The first crystal structure of a LOX [57] from Soybean, described by Boyington et al., 
established the molecular framework common to both plant and animal enzyme.  Crystal 
structure of lipoxygenase bears two major domains: an amino terminal β-barrel, now 
known as a PLAT (Polycystin-1, Lipoxygenase, Alpha-Toxin) domain and a much larger 
α-helical domain that houses the catalytic iron [58]. The plant enzymes are significantly 
larger than the animal enzymes (∼900 vs. ∼650 amino acids, respectively), and the 
smaller animal enzymes are simply trimmed down by the omission of several plant-
specific loop regions. Despite the differences, a large helical core, along with the relative 
placements of most of the ∼17 helices that comprise it, is conserved. At the heart of the 
core is the catalytic iron, positioned by invariant histidine side chains contributed by the 
two longest helices in the common core as well as the main chain carboxyl at the C-
terminus provided by an invariant Ile. An unusual structural feature of helix α8, a unique 
insertion which gives it a distinct curvature [59] has been observed in all LOX structures 
to date. Some inhibitors have been reported to bind either directly or indirectly to the 
adjacent amino acid residues of cofactor [60-62].  
 
3.7.3. Molecular docking and Binding Analysis 
For elucidation of the molecular basis of the mechanism of inhibition for synthesized 
hydrazones (1-3), the compounds were docked computationally to the active site of 
soybean LOX. In this study, first the protein structure (1IK3: 2.0 Å) was retrieved from 
Protein Data Bank (PDB). The protein was already bound with four ligands in its crystal 
structure i.e. 13(S)-hydroperoxy-9(Z),11(E)-octadecadienoic acid; 13(R)-hydroperoxy-
9(Z),11(E)-octadecad ienoic acid; (trans-12,13-epoxy)-9-hydroxy-10(E)-octadecenoic 
acid; trans-12,13-epoxy)-11-hydroxy-9(z)-octadecenoic acid along with Fe(III) as a 
cofactor. The prominent amino acid residues involved in non-bonding interactions are 
Phe576, Ser510, Ile572, Arg726, HOH870, Gly720, His513, His518, His523, Leu565, 
Leu560, Ile557, Ile857, Leu277, Leu773 and Ile772 in the α-helical domain. The bound 
cocrystallized ligands were removed from active pocket of protein keeping the cofactor 
iron (Fe3+) intact to study the inhibition mechanism of the active compounds. 
To investigate the orientation of synthesized compounds, (E)-N'-(2-
propoxybenzylidene)-4-methoxybenzohydrazide (1), (E)-N'-(4-(nonyloxy)benzylidene)-
2-phenylacetohydrazide (2), (E)-N'-(4-butoxybenzylidene)-4-nitrobenzohydrazide (3) 
and the reference compound indomethacin in the active pocket, all compounds were 





































































docked into the active site of LOX (PDB code: 1IK3) using Autodock Vina. The results 
of molecular docking calculations were recorded in 20 different conformations for each 
compound. Most of the favored conformations occupy pocket area towards α-helical 
domain however some of the less favored conformations occupied the peripheral region 
towards the PLAT domain. Variants with the minimal energy of enzyme–inhibitor 
complex were chosen for further study. 
 
Table 7. Inhibitory activity against LOX and binding affinity of all ligands. 

























 Indomethacin 48.25±1.71 -8.3 
 
Figure 9. An overlay of the docked orientations of the most preferred conformations of 
compounds 1, 2, 3 and indomethacin in the active pocket of lipoxygenase (cyan) shown 
in ribbons (Left). Mesh surface view of ligands enzyme complex (Right). Relative 





































































positioning of all 3 variants in the  active pocket was shown. Minimal energy 
conformations of indomethacin were shown in blue and compounds 1, 2 and 3 were 
shown in green, red and yellow, respectively.  
 
Figure 9 illustrates the relative positioning of hydrazones 1-3 and indomethacin in their 
minimal energy conformation (out of 20 different conformations for each compound) in 
the active site of Lipoxygenase. The corresponding binding energies of ligands with most 
preferred conformation are shown in Table 7. As can be seen, the hydrazones 1-3 
preferred to bind the enzyme at a place different in position to that for indomethacin 
owing to the fact that hydrazones are different in structure than indomethacin (Figure 9). 
Compounds 1-3 have potential to block the entry of substrate by binding to amino acid 
residues lying near the pocket opening of α-helical domain. A more bent conformation is 
adapted by 2 (red) (Figure 9) as compared to 1 (green) (Figure 9). The enzyme/inhibitor 
complexes are stabilized by hydrogen bonds in the hydrophilic region and by π···π and 
vdW interactions in the hydrophobic region. It has been observed from the binding 
interactions that the hydrazones interact differently as compared to the interactions of 
indomethacin (Figure 9) owing to the different structures of compounds 1-3 bearing 
hydrazone moiety as compared to carboxylic acid moiety of indomethacin along with 
other structural differences besides their positioning in pocket architecture (Figure 9).  
 






































































Figure 10. Docking pose of ligands in 3D and 2D display; A) Compound 1 (green), B) 
Compound 3 (yellow).  Ligands are shown in stick mode while receptor is shown in cyan 
colored ribbons and key residues are shown in stick mode. 2D-Interaction diagram of 
compound 1 and 3 are represented in C and D, respectively. 
 
The reason for high inhibitory activity of compound 3 as compared to other analogs can 
be explained by molecular docking studies (Figure 10). Compound 3 showed pronounced 
hydrogen bond interactions as compared to compounds 1, 2 and indomethacin. The 
oxygen of butyloxy chain forms hydrogen bond with His548 at a distance 2.52 Å, while 
the oxygen of hydrazone moiety forms hydrogen bond with main chain amide of Phe162. 
The greater binding affinity of this hydrazine is mainly attributed to the presence of a 
nitro group in the phenyl ring of hydrazide moiety. The nitro group plays an important 
role by forming four hydrogen bonds with the nearby polar residues. Both the oxygens of 
nitro functionality form hydrogen bonds with Arg200 at a distance of 2.67 Å and 2.85 Å. 
In addition, the NH of Arg159 forms hydrogen bond with the O-atom of nitro group. The 
interactions of positive Arginine residue with the negative nitro functionality can also be 
considered as salt bridge interactions. In addition, the fourth hydrogen bond is formed 
between oxygen of nitro functionality and Ser147. All these types of hydrogen bonds 










































































ligands. In addition to hydrogen bonding interactions, the molecule interacted with the 
binding site via π···π stacking, π-alkyl and alkyl-alkyl interations. 4-nitro phenyl moiety 
of the benzohydraide analog interacts with Phe161 displaying T shaped π···π interaction 
with a distance of 4.92 Å. Both phenyl rings of compound 3 interact with Val539 (5.04 
Å) and Val144 (5.28 Å) showing π-alkyl interactions. However, in 1, phenyl ring bearing 
4-methoxy functionality forms cation···π interaction with Lys545 at a distance of 4.32Å 
while the phenyl ring bearing propyloxy chain forms T-shaped π···π interactions. The 
protein-ligand complex was further stabilized by weaker hydrogen bond between Lys545 
and the O-atom of hydrazone. In addition some weaker interactions were observed 
between propyloxy chain of compound 1 and Leu187 and Val539 forming π-alkyl 
interactions.  The analysis showed that compound 3 showed strong hydrogen bonding 
interactions with target as compared to compound 1 (see Fig. 10). 
 
 
Figure 11. Docking pose of ligand in 3D and 2D display; (Left) Compound 2 (red) shown 
in stick mode while receptor is shown in cyan colored ribbons and key residues are shown 
in stick mode. (Right) 2D-Interaction diagram of compound 2. 
 
Docking analysis of compound 2 is represented in Figure 11. As already stated, the 
hydrazone 2 adopts a bent conformation as there were 14 number of rotatable bonds. In 
this molecule only one hydrogen bond is observed between the NH and the main chain 
amide of Val144 at a distance of 2.3 Å. The rest of the interactions observed between 2 
and LOX enzyme were pi-alkyl (Pro789, Pro549),  pi-sigma (Val539) and vdW 
interactions (Tyr544, Trp791, Cys145, Val540, Ile160, Glu183). Phenyl ring of hydrazide 
moiety formed T-shaped π···π stacking with Phe161 residue. Binding analysis showed 





































































that the alkoxy aryl hydrazones 1 and 3 interacted more with polar amino acid residues 
(Figure 10) however hydrazone 2 showed more interaction with nonpolar amino acid 
residues (Figure 11). The compound showed weak binding affinity and weaker 
interactions therefore less active than 1 and 3.  
The docking results showed that compound 3 forms stronger binding interactions with 
the target molecule followed by compounds 1 and 2. The molecular docking result is in 
good agreement with bioactivity data against lipoxygenase. This observation correlates 
well with the bioassay results, in which compound 3 exhibited higher potency than other 
ligands because the molecule participates in strong hydrogen bonding interactions with 
the aforementioned amino acid residues.  
 
4. Conclusions 
Three new hydrazide based Schiff bases (1-3) have been synthesized and structurally 
characterized. The crystal structure of compounds 1 and 2 were solved by X-ray 
diffraction methods. In this work, we have performed a detailed quantitatively analysis 
on the intermolecular interactions present in the crystal structure of both compounds. The 
crystal packing of 1 and 2 are stabilized by strong N-H···O hydrogen bonds. In addition, 
the crystal structure of the compounds shows several relatively weak interactions such as 
C-H···O, C-H···N hydrogen bonds and C-H···π interactions. In the case of the structure 
of 2, weak π···π stacking interactions were observed. This study clearly shows that the 
energetic distribution in the crystal packing is anisotropic as clearly evident analyzing the 
energy frameworks diagrams. Analysis of the energy associated with the intermolecular 
interactions has been also conducted by using DFT calculations and corroborated by 
NCIplots and QTAIM approach, confirming their importance in the supramolecular 
assembly of both compounds. In brief, the substituents and the substitution positions play 
an important role in the packing mode, intermolecular hydrogen bonding and structural 
conformation of the studied compounds. 
All the synthesized substituted alkoxybenzylidene benzohydrazides and 
phenylacetohydrazides were evaluated against soybean lipoxygenase enzyme using 
indomethacin as a standard drug. The compounds were found to be the inhibitors of 
soybean lipoxygenase. Structure activity relationship shows that the substituted 
alkoxybenzylidene benzohydrazides were found to inhibit Lipoxygenase enzyme to a 
greater extent as compared to alkoxybenzylidene phenylacetohydrazide.  Putative binding 
modes and comparison of binding interactions of the protein ligand complex were also 





































































analyzed by molecular docking studies in order to rationalize theoretical and experimental 
studies. 
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Three Hydrazide-based Schiff bases have been synthesized and characterized by IR, UV-
vis and X-ray diffraction methods. A detail analysis of intermolecular interactions has 
been performed by Hirshfeld surface analysis and DFT calculations.
Page 35 of 35 CrystEngComm
C
ry
st
E
ng
C
om
m
A
cc
ep
te
d
M
an
us
cr
ip
t
Pu
bl
is
he
d 
on
 0
7 
D
ec
em
be
r 
20
20
. D
ow
nl
oa
de
d 
by
 G
ot
eb
or
gs
 U
ni
ve
rs
ite
t o
n 
12
/1
6/
20
20
 1
1:
14
:4
5 
A
M
. 
View Article Online
DOI: 10.1039/D0CE01402H
